Dimethyl fumarate treatment in relapsing remitting MS changes the inflammatory CSF protein profile by a prominent decrease in T-helper 1 immunity
出版年份 2023 全文链接
标题
Dimethyl fumarate treatment in relapsing remitting MS changes the inflammatory CSF protein profile by a prominent decrease in T-helper 1 immunity
作者
关键词
-
出版物
Multiple Sclerosis and Related Disorders
Volume -, Issue -, Pages 105126
出版商
Elsevier BV
发表日期
2023-11-06
DOI
10.1016/j.msard.2023.105126
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of early neurodegenerative pathways in progressive multiple sclerosis
- (2022) Max Kaufmann et al. NATURE NEUROSCIENCE
- High-dimensional immune profiling identifies a biomarker to monitor dimethyl fumarate response in multiple sclerosis
- (2022) Martin Diebold et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunological effects of dimethyl fumarate treatment in blood and CSF of patients with primary progressive MS
- (2021) J. Talbot et al. JOURNAL OF NEUROIMMUNOLOGY
- Inflammation-related plasma and CSF biomarkers for multiple sclerosis
- (2020) Jesse Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Current and emerging disease‐modulatory therapies and treatment targets for multiple sclerosis
- (2020) F. Piehl JOURNAL OF INTERNAL MEDICINE
- Semaphorin4A causes loss of mature oligodendrocytes and demyelination in vivo
- (2019) Brian Chiou et al. Journal of Neuroinflammation
- GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis
- (2019) Edoardo Galli et al. NATURE MEDICINE
- Dimethyl Fumarate: A Review in Relapsing-Remitting MS
- (2019) Hannah A. Blair DRUGS
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Dimethyl fumarate treatment in multiple sclerosis: Recent advances in clinical and immunological studies
- (2018) Gwendoline Montes Diaz et al. AUTOIMMUNITY REVIEWS
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients
- (2017) Qi Wu et al. JOURNAL OF IMMUNOLOGY
- Nrf2, cellular redox regulation, and neurologic implications
- (2017) Eduardo E. Benarroch NEUROLOGY
- Pharmacodynamics of Dimethyl Fumarate Are Tissue Specific and Involve NRF2-Dependent and -Independent Mechanisms
- (2016) Melanie S. Brennan et al. ANTIOXIDANTS & REDOX SIGNALING
- Complex heatmaps reveal patterns and correlations in multidimensional genomic data
- (2016) Zuguang Gu et al. BIOINFORMATICS
- Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
- (2015) Erin E Longbrake et al. Multiple Sclerosis Journal
- NAD+ in aging, metabolism, and neurodegeneration
- (2015) E. Verdin SCIENCE
- Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
- (2015) Erin E Longbrake et al. Multiple Sclerosis Journal
- Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate’s protective effect in EAE
- (2014) Hui Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Semaphorins and plexins as therapeutic targets
- (2014) Thomas Worzfeld et al. NATURE REVIEWS DRUG DISCOVERY
- Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
- (2014) Erika Assarsson et al. PLoS One
- The Role of Neurotrophins in Multiple Sclerosis—Pathological and Clinical Implications
- (2012) Alicja Kalinowska-Lyszczarz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Elevation of Sema4A Implicates Th Cell Skewing and the Efficacy of IFN- Therapy in Multiple Sclerosis
- (2012) Y. Nakatsuji et al. JOURNAL OF IMMUNOLOGY
- Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
- (2011) Mübeccel Akdis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Roles of Sema4D-Plexin-B1 Interactions in the Central Nervous System for Pathogenesis of Experimental Autoimmune Encephalomyelitis
- (2009) T. Okuno et al. JOURNAL OF IMMUNOLOGY
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
- (2009) Eva Havrdova et al. LANCET NEUROLOGY
- Homeostasis of Naive and Memory T Cells
- (2008) Charles D. Surh et al. IMMUNITY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started